Cure Discussion - Ovarian cancer

Lynparza

Lynparza

My mother begin Lynparza treatment on November 4/2015. She is BRCA2, she is 80years old. Prior of been diagnosis with ovarian cancer she was never sick, take no medications, she was a very active g...

Making the Case for Neoadjuvant Chemotherapy in Ovarian Cancer

Making the Case for Neoadjuvant Chemotherapy in Ovarian Cancer

Neoadjuvant chemotherapy is increasingly used in advanced ovarian cancer, even though it has not been shown to improve survival versus primary cytoreduction, according to Thomas J. Herzog, clinical...

Expert Cautious About Immunotherapy for Ovarian Cancer

Expert Cautious About Immunotherapy for Ovarian Cancer

Early promising responses seen with immune checkpoint inhibitors for patients with ovarian cancer still need to be validated in larger randomized trials before a conclusion is made regarding their ...

Long-Term Ovarian Cancer Survival Higher Than Thought

Long-Term Ovarian Cancer Survival Higher Than Thought

An analysis of data collected on thousands of ovarian cancer patients in California turned up some promising news for women with this diagnosis. While the study, conducted by researchers at UC Davi...

IP/IV Chemo Improves Overall Survival in Ovarian Cancer

IP/IV Chemo Improves Overall Survival in Ovarian Cancer

Though intraperitoneal (IP) chemotherapy along with intravenous (IV) therapy may add 16 months or more to the lives of women with ovarian cancer, less than half of these patients at U.S. hospitals ...